A company has engineered an E. coli strain that makes a human protein at a high rate in small laboratory flasks. When production is moved to a large bioreactor, two problems appear:
Problem 1: the temperature and oxygen supply vary from one part of the vessel to another, and the yield per litre falls.
Problem 2: the protein recovered at the end is mixed with other materials from the cells and the medium.
Which of the three critical research areas of biotechnology need further work?
